Noumegni Steve Raoul, Bigna Jean Joel, Ama Moor Epse Nkegoum Vicky Jocelyne, Nansseu Jobert Richie, Assah Felix K, Jingi Ahmadou Musa, Guewo-Fokeng Magellan, Leumi Steve, Katte Jean-Claude, Dehayem Mesmin Y, Mfeukeu Kuate Liliane, Kengne Andre Pascal, Sobngwi Eugene
Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.
Faculty of Medicine, University of Paris Sud XI, Le Kremlin Bicêtre, France.
BMJ Open. 2017 Aug 11;7(8):e016835. doi: 10.1136/bmjopen-2017-016835.
Cardiovascular disease (CVD) and metabolic diseases are growing concerns among patients with HIV infection as a consequence of the improving survival of this population. We aimed to assess the relationship between CVD risk and insulin resistance in a group of black African individuals with HIV infection.
This cross-sectional study involved patients with HIV infection aged 30-74 years and followed up at the Yaoundé Central Hospital, Cameroon. Absolute CVD risk was calculated using the Framingham and the DAD CVD risk equations while the HOMA-IR index was used to assess insulin resistance (index ≥2.1).
A total of 452 patients (361 women; 80%) were screened. The mean age was 44.4 years and most of the respondents were on antiretroviral therapy (88.5%). The median 5-year cardiovascular risk was 0.7% (25th-75th percentiles: 0.2-2.0) and 0.6% (0.3-1.3) according to the Framingham and DAD equations respectively. Of all participants, 47.3% were insulin resistant. The Framingham equation derived absolute CVD risk was significantly associated with insulin resistance; while no linear association was found using the DAD equation.
The relationship between cardiovascular risk and insulin resistance in black African patients with HIV infection seems to depend on the cardiovascular risk equation used.
由于感染人类免疫缺陷病毒(HIV)人群的生存率不断提高,心血管疾病(CVD)和代谢性疾病日益受到关注。我们旨在评估一组感染HIV的非洲黑人个体中CVD风险与胰岛素抵抗之间的关系。
这项横断面研究纳入了年龄在30至74岁之间、在喀麦隆雅温得中心医院接受随访的HIV感染患者。使用弗明汉和DAD心血管疾病风险方程计算绝对CVD风险,同时使用HOMA-IR指数评估胰岛素抵抗(指数≥2.1)。
共筛查了452名患者(361名女性;80%)。平均年龄为44.4岁,大多数受访者正在接受抗逆转录病毒治疗(88.5%)。根据弗明汉方程和DAD方程,5年心血管疾病风险的中位数分别为0.7%(第25至75百分位数:0.2 - 2.0)和0.6%(0.3 - 1.3)。在所有参与者中,47.3%存在胰岛素抵抗。弗明汉方程得出的绝对CVD风险与胰岛素抵抗显著相关;而使用DAD方程未发现线性关联。
感染HIV的非洲黑人患者心血管疾病风险与胰岛素抵抗之间的关系似乎取决于所使用的心血管疾病风险方程。